Targeted PI3K/AKT/mTOR therapy for metastatic carcinomas of the cervix: A phase I clinical experience.
Hou MM, Liu X, Wheler J, Naing A, Hong D, Coleman RL, Tsimberidou A, Janku F, Zinner R, Lu K, Kurzrock R, Fu S.
Hou MM, et al. Among authors: kurzrock r.
Oncotarget. 2014 Nov 30;5(22):11168-79. doi: 10.18632/oncotarget.2584.
Oncotarget. 2014.
PMID: 25426553
Free PMC article.
Clinical Trial.